<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="43437">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01768325</url>
  </required_header>
  <id_info>
    <org_study_id>1104-03</org_study_id>
    <nct_id>NCT01768325</nct_id>
  </id_info>
  <brief_title>Evaluation of a New EUS-guided Needle (ProCore) Comparing to EUS-TCB Needle (Quick-Core)</brief_title>
  <official_title>Evaluation of a New EUS-guided Needle (ProCore) Comparing to Conventional EUS-TCB Needle (Quick-Core); A Prospective Randomized, Controlled Multi-center Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate a new EUS-guided biopsy needle (ProCore®) comparing
      it to conventional EUS-TCB needle (Quick-Core®) in the diagnosis of your suspicious
      disorder.

      This study needle (ProCore®) is a new EUS-guided biopsy needle and has been recently
      approved by the U.S. Food and Drug Administration (FDA) for use.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary Objective To compare the diagnostic accuracy of new EUS histology needle (19G,
      ProCore, Cook Medical Inc., Winston-Salem, NC) with the conventional histology needle (19G,
      Quick-Core, Cook Medical Inc., Winston-Salem, NC)

      Secondary Objective To compare

        -  The number of needle passes requiring to acquire adequate specimen

        -  Length of core tissue obtained

        -  Diagnostic contribution of immunohistochemical staining

        -  Rates of complications
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">January 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>The size of core biopsy obtained by the ProCore and QuickCore biopsy needles. Larger core iopsy specimen-yield.</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>To compare the diagnostic accuracy of new EUS histology needle (19G, ProCore, Cook Medical Inc., Winston-Salem, NC) with the conventional histology needle (19G, Quick-Core, Cook Medical Inc., Winston-Salem, NC)</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">76</enrollment>
  <condition>Gastrointestinal Tumors.</condition>
  <arm_group>
    <arm_group_label>Core Biopsy Needle Comparison</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Comparison of ProCore core biopsy needle to QuickCore core biopsy needle.Cook Medical core biopsy needle</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Comparison of core biopsy needles</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Comparison of core biopsy needles.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ProCore needle</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Core biopsy needle comparison to obtain diagnostic yield.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cook Medical core biopsy needle</intervention_name>
    <description>Obtaining a larger specimen.</description>
    <arm_group_label>Core Biopsy Needle Comparison</arm_group_label>
    <arm_group_label>Comparison of core biopsy needles</arm_group_label>
    <arm_group_label>ProCore needle</arm_group_label>
    <other_name>Biopsy needle comparison to QuikCore needle.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Solid tumors ≥ 2 cm in size.

        Exclusion criteria:

          -  Thrombocytopenia
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John M. DeWitt, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University 550 N. University Hospital UH 4100 Indianapolis, IN 46202-5121</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kathleen A. McGreevy, R.N.</last_name>
    <phone>317-944-5392</phone>
    <email>kmcgreev@iupui.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Indiana University Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202-5121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 28, 2014</lastchanged_date>
  <firstreceived_date>January 9, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ProCore Needle</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Digestive System Neoplasms</mesh_term>
    <mesh_term>Gastrointestinal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
